Physician profile
Jed A Bell
NPI 1003081449
$1,112.71
in general payments reported to CMS, 2019-2025
21 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $199 · 2021: $18.39 · 2022: $84.12 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $173.55 | 2019-2025 | |
| Pfizer INC. | $133.06 | 2019-2020 | |
| Nevro Corp. | $100.51 | 2019-2020 | |
| Stryker Corporation | $84.12 | 2022 | |
| Amgen INC. | $77.65 | 2019-2020 | |
| Boston Scientific Corporation | $75.03 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.65 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $62.15 | 2019-2020 | |
| Abbott Laboratories | $43.30 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $36.27 | 2019 | |
| Medtronic, INC. | $35.46 | 2021-2025 | Inceptiv |
| Biodelivery Sciences International, INC. | $34.83 | 2019 | |
| Daiichi Sankyo INC. | $31.06 | 2019 | |
| Arbor Pharmaceuticals, INC. | $29.74 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $27.28 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $26.70 | 2025 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $20.74 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.25 | 2019 | |
| Lilly USA, LLC | $12.11 | 2020 | |
| Assertio Therapeutics, INC. | $11.96 | 2019 | |
| Horizon Therapeutics Plc | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jed Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.